Welcome to kongre.net
Speaker
Vice President, Diagnostic Strategy, Madrigal Pharmaceuticals
Suneil Hosmane, Vice President, Diagnostic Strategy at Madrigal Pharmaceuticals, spoke at 10th MASH Drug Development Summit 2026 (Boston, United States of America, 15–17 Sept 2026) in the session “Advancing Imaging & Non-Invasive Biomarker Strategies to Improve Endpoint Interpretation, Enable Earlier Decision-Making & Support Registrational Success in Mash”.
15–17 Sept 2026Boston, United States of America
Director, Madrigal Pharmaceuticals
Senior Director, Cellarity
Chief Executive Officer, Cirius Therapeutics
Faculty, Harvard Medical School and Mass General Brigham
Associate Director, Clinical Research, Akero Therapeutics
Vice President, Discovery Biology, Sepia Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Suneil Hosmane, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].